The independent source for health policy research, polling, and news.
1,041-1,060 of 113,253 results
The court intervened at the behest of two manufacturers of mifepristone on Thursday, after the U.S. Court of Appeals for the Fifth Circuit restricted access to the drug nationwide. The order means that the Fifth Circuit’s decision will remain blocked while litigation continues in the lower courts. The issue could eventually return to the high court.
Today's early morning highlights from the major news organizations.
Editorial writers delve into these public health issues.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
New measures signed by Gov. Abigail Spanberger, a Democrat, limit the out-of-pocket cost of insulin to $35 and expand what insurance plans must cover. The laws go into effect July 1. Also: Iowa enacts prior authorization reform; and more.
An analysis of the 2023 National Immunization Survey-Teen found that states in the Northeast census region had significantly higher odds of HPV vaccine uptake, while states in the South had significantly lower odds, CIDRAP reports. The HPV vaccine is credited with lowering the cervical cancer risk by 80% in women vaccinated by age 16 and by 66% in those vaccinated after 16.
Fierce Healthcare reports that nurses feel they have more time with patients and are more accepting of AI in the workplace. Doctors, on the other hand, are more skeptical of new technologies, as they already feel overburdened and lack the time to adjust to the latest technology.
The Wall Street Journal reports that deaths have declined for three years in a row, falling to prepandemic levels, according to preliminary data from the CDC released Wednesday. Also in public health news: alcohol's effect on the body, poisonous wild mushrooms in California, parkour for older adults, and more.
Modern Healthcare reports that the pause is part of the agency's latest effort to address fraud in the healthcare system. Also: CMS rolls out prior authorization plan; news outlets continue their coverage on Marty Makary's exit from the FDA; and more.
The Hill reports on messaging out of the CDC, including that "the risk to the general public is low." Also: why germs spread on cruise ships and how parents can discuss hantavirus with children.
Today's early morning highlights from the major news organizations.
Opinion writers examine these public health issues.
The New York Times reports on daraxonrasib, the first drug to substantially extend the lives of patients with pancreatic cancer. The cellular proteins it targets fuel the three leading causes of cancer deaths: pancreatic tumors, lung, and colon cancers. The drug is fast-tracked for review by the Food and Drug Administration and could win approval later this year.
According to The 19th, the federal government wants access to the medical records of children who have received gender-affirming care over the past six years. Also: Some states are trying to roll back disability rights; 25,000 UC Health workers are set to strike; and more.
A recent JAMA study reveals that nearly 7 million U.S. children live in homes with at least one loaded, unlocked gun. Also in the news: suicide, the yo-yo diet effect, testosterone, and more.
Hundreds of thousands of patients' records from health systems across the country have been compromised, The Washington Post reports. This underscores the necessity for health IT officials and executives to close security gaps in the electronic network used to transfer medical records between hospitals, physicians’ offices, and laboratories.
Politico reports that Marty Makary’s time leading the FDA saw mass layoffs, ongoing churn among senior leaders, and policy fights. Meanwhile, Fox News reports that the FDA has approved the first-ever non-antipsychotic drug treatment for agitation in Alzheimer’s disease patients.
Minnesota is monitoring a resident who might have been exposed to the virus by a passenger of the MV Hondius, while Illinois health officials are investigating a potential case that they don't think is related to the cruise ship outbreak. Meanwhile, a mishmash of strategies to stop the spread is complicating the global response to the outbreak.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
© 2026 KFF